YOLFTbeta
33

Precision Biosensor Inc.

335810 · KQ · Healthcare / Medical Devices

1,372.00KRW-7.00 (-0.51%)

Price History

Full chart

Market Stats

Previous Close1,379.00
Open1,379.00
Day Range1,339.00 – 1,395.00
52-Week Range1,106.00 – 3,505.00
Volume6.26K
Market Cap32.51B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.42
50-Day Avg1,455.84
200-Day Avg2,016.12

About

Precision Biosensor, Inc. engages in the development, production, and sale of immune diagnostic kits in South Korea. It offers Exdia TRF Plus, an immunodiagnosis POCT platform; and Exdia PT10 and Exdia PT10S, a clinical chemistry POCT platform. The company was founded in 2009 and is headquartered in Daejeon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOHan-Shin Kim
  • Employees98
  • Headquarters306, Techno 2-ro, Daejeon, South Korea, 34036, Korea
  • Websitehttps://precision-bio.com

Leadership

  • Han-Shin KimCEO & Director · b. 1968
  • Seunghoon LeeChief Financial Officer · b. 1973
  • Jongmyeon ParkChief Technology Officer

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.41B4.59B6.20B8.68B15.89B20.46B20.39B19.13B19.93B
Growth (%)-+4.13%+35.23%+39.97%+82.93%+28.77%-0.33%-6.16%+4.14%
Cost of Revenue2.16B2.66B3.43B3.92B11.28B13.70B12.71B12.95B13.51B
Gross Profit2.25B1.93B2.77B4.77B4.60B6.75B7.69B6.18B6.42B
Gross Margin51.02%41.97%44.68%54.89%28.98%33.02%37.69%32.31%32.22%
Operating Expense4.45B4.77B5.41B6.23B8.59B11.25B12.14B11.23B11.80B
Operating Income-2.21B-2.84B-2.64B-1.46B-3.98B-4.50B-4.46B-5.05B-5.38B
Operating Margin-50.07%-61.89%-42.49%-16.86%-25.08%-22.00%-21.85%-26.38%-27.01%
EBITDA------3.91B-1.01B-1.39B-3.95B
EBITDA Margin------19.09%-4.94%-7.26%-19.82%
Net Income-2.45B-4.04B-405.34M-4.95B-4.15B-6.81B-4.49B-7.31B-10.02B
Net Income Margin-55.71%-88.05%-6.53%-57.03%-26.14%-33.27%-22.02%-38.18%-50.30%
R&D---2.05B1.96B2.61B3.20B3.59B2.58B
R&D as % of Total Revenue---23.55%12.33%12.76%15.68%18.74%12.97%
Interest Expense00023.57M162.10M816.95M1.23B1.99B2.10B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.27%1.02%3.99%6.03%10.40%10.52%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets15.42B12.44B21.25B42.28B55.72B59.01B62.48B52.04B53.07B
Total Liabilities12.88B13.96B9.93B5.06B17.37B25.63B30.45B26.34B20.31B
Total Equity2.55B-1.52B11.32B37.22B38.35B33.38B32.03B25.70B32.77B
Cash517.62M1.46B179.70M21.90B5.54B7.56B2.43B1.72B3.29B
Total Debt310.51K-368.98M672.74M-----
Net Debt----3.78B6.56B16.00B14.61B10.09B

Cash Flow

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.81B-2.85B-2.08B-4.84B-4.57B-2.58B-1.95B-1.44B-1.51B
Investing Cash Flow-475.08M3.80B-9.94B6.56B-29.18B142.17M-9.93B5.58B-
Financing Cash Flow7.94B-310.51K10.73B20.05B17.45B4.21B6.72B-5.01B-
Capital Expenditure520.84M404.96M216.43M2.11B9.15B11.14B7.05B64.96M157.43M
Free Cash Flow----6.95B-13.75B-17.50B-9.01B-1.51B-1.67B
FCF to OCF---143.60%300.61%679.46%461.11%104.50%110.41%

Earnings

Report DateDec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual30.43-85.80-88.00-57.94-135.81-10.58-209.04-187.78-180.48-28.51-39.64-116.15-202.44-144.46-122.95-219.68-141.88-173.56-231.60-131.08-257.806.51-53.01
Surprise-----------------------
Timing-----------------------

Key Statistics & Ratios

Market Cap32.51B
Enterprise Value37.02B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.37
Price / Book0.78
Revenue (TTM)23.66B
Gross Profit (TTM)8.85B
EBITDA231.27M
Profit Margin-26.85%
Operating Margin-19.45%
Return on Equity-20.16%
Return on Assets-4.12%
Shares Outstanding21.88M
Shares Float8.99M
Beta0.42
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%